This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, Y.
Right arrow Articles by Wallace, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, Y.
Right arrow Articles by Wallace, R. J., Jr.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, January 2004, p. 119-125, Vol. 42, No. 1
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.1.119-125.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Molecular Analysis of Mycobacterium kansasii Isolates from the United States

Yansheng Zhang,1* Linda B. Mann,1 Rebecca W. Wilson,1 Barbara A. Brown-Elliott,1 Véronique Vincent,2 Yoshitsugu Iinuma,3,{dagger} and Richard J. Wallace Jr.1

Department of Microbiology, The University of Texas Health Center, Tyler, Texas,1 Laboratoire de Référence des Mycobactéries, Pasteur Institute, Paris, France,2 Department of Clinical Laboratory Medicine, Nagoya University Hospital, Nagoya, Japan3

Received 28 March 2003/ Returned for modification 29 May 2003/ Accepted 26 September 2003

We studied the population genetics of Mycobacterium kansasii isolates from the United States by PCR restriction enzyme analysis (PRA) of the 441-bp Telenti fragment of the hsp-65 gene and pulsed-field gel electrophoresis (PFGE) of genomic DNA with the restriction endonucleases AseI, DraI, and XbaI, and we compared the patterns to those previously reported from France and Japan. By PRA, 78 of 81 clinical isolates (96%) from the United States belonged to subspecies I. With PFGE, 28 AseI patterns, 32 DraI patterns, and 35 XbaI patterns were produced. PFGE showed marked clonality of the U.S. isolates, with differences between genotypes involving only one or two bands. Isolates within Texas showed lower pattern diversity than those from different states. With DraI, 31 of 71 isolates (44%) had the same common PFGE pattern, which matched the predominant pattern in France (pattern Ia), determined by Picardeau et al. (M. Picardeau, G. Prod'hom, L. Raskine, M. P. LePennec, and V. Vincent, J. Clin. Microbiol. 35:25-32, 1997), and in Japan (type M), determined by Iinuma et al. (Y. Iinuma, S. Ichiyama, Y. Hasegawa, K. Shimokata, S. Kawahara, and T. Matsushima, J. Clin. Microbiol. 35:596-599, 1997). With AseI, 42% of isolates produced a common pattern indistinguishable from the common pattern seen in French isolates (Ia) and with only one band difference from the common pattern (type M) in Japan. This study demonstrates that subspecies I is the predominant subspecies of M. kansasii among clinical isolates in the United States, as it is in Europe and Japan, and that genotype I is highly clonal worldwide, with the same major genotype responsible for human infection. The fact that a single clone of M. kansasii is responsible for most cases of human disease suggests that specific virulence factors may be associated with this specific genotype.

* Corresponding author. Mailing address: The University of Texas Health Center, Department of Microbiology, 11937 U.S. Highway 271, Tyler, TX 75708. Phone: (903) 877-7683. Fax: (903) 877-7652. E-mail: yansheng.zhang{at}uthct.edu.

{dagger} Present address: Department of Clinical Laboratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Journal of Clinical Microbiology, January 2004, p. 119-125, Vol. 42, No. 1
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.1.119-125.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Griffith, D. E., Aksamit, T., Brown-Elliott, B. A., Catanzaro, A., Daley, C., Gordin, F., Holland, S. M., Horsburgh, R., Huitt, G., Iademarco, M. F., Iseman, M., Olivier, K., Ruoss, S., von Reyn, C. F., Wallace, R. J. Jr., Winthrop, K., on behalf of the ATS Mycobacterial Diseases Subcom, (2007). An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases. Am. J. Respir. Crit. Care Med. 175: 367-416 [Full Text]  
  • Richter, E., Rusch-Gerdes, S., Hillemann, D. (2006). Evaluation of the GenoType Mycobacterium Assay for Identification of Mycobacterial Species from Cultures.. J. Clin. Microbiol. 44: 1769-1775 [Abstract] [Full Text]  
  • da Silva Telles, M. A., Chimara, E., Ferrazoli, L., Riley, L. W (2005). Mycobacterium kansasii: antibiotic susceptibility and PCR-restriction analysis of clinical isolates. J Med Microbiol 54: 975-979 [Abstract] [Full Text]  
  • Loddenkemper, K, Enzweiler, C, Loddenkemper, C, Backhaus, M, Burmester, G-R, Buttgereit, F (2005). Granulomatous synovialitis with erosions in the shoulder joint: a rare case of polyarthritis caused by Mycobacterium kansasii. Ann Rheum Dis 64: 1088-1090 [Full Text]  
  • Alcaide, F., Calatayud, L., Santin, M., Martin, R. (2004). Comparative In Vitro Activities of Linezolid, Telithromycin, Clarithromycin, Levofloxacin, Moxifloxacin, and Four Conventional Antimycobacterial Drugs against Mycobacterium kansasii. Antimicrob. Agents Chemother. 48: 4562-4565 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»